Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Since the start of the pandemic, the CAMS-Oxford Institute (COI) has carried out 11 projects to better understand COVID-19, resulting in 21 published research articles.

The COVID-19 research projects undertaken by the COI, in collaboration with different units in the Nuffield Department of Medicine and other departments in the Medical Sciences Division, have made an impactful contribution to the understanding of COVID-19 pathology and immunology.

Below are the highlights of their research:

  • Understanding T cell responses to SARS-COV-2
    Prof. Tao Dong and her group identified the epitopes that illicit strong T-cell responses across a range of HLA types, which helped to inform vaccine design.
  • Understanding antibody responses to SARS-COV-2
    Multiple studies examined antibody responses to SARS-COV-2, and the mutations in spike protein helped to campaign for the inclusion of the omicron spike in a bivalent vaccine.
  • Understanding the effect of host genetics on disease severity
    The study identified immune signatures and correlates of host response and advanced the development of new drugs and personalised medicine approaches in the treatment of COVID-19.
  • Understanding immune responses following vaccination
    Multiple studies looked into the correlates of protection against symptomatic and asymptomatic infection, which play an integral role in the development of vaccines.
  • Understanding SARS-COV-2 pathogenesis
    In addition to the immune responses, researchers also studied viral replication, host responses, and associated COVID-19 pathogenesis.

 For more details on the research papers visit the COI Website.

Similar stories

Landmark antibody study to test immune responses against COVID-19

Four UK centres will conduct the ‘Stratification of Clinically Vulnerable People for COVID-19 Risk using Antibody Testing (STRAVINSKY)’ study over the next two years, to identify the patient groups most vulnerable to COVID-19.

New partnership to combat deadly pathogens

The Pandemic Sciences Institute and the UK's Defence Science and Technology Laboratory (Dstl) have agreed to jointly study the dangerous pathogens that could cause future pandemics.

Benemérita Universidad Autónoma de Puebla representatives visit Jenner Institute

Academic representatives from Benemérita Universidad Autónoma de Puebla (BUAP), one of the leading universities in Mexico, paid a visit to NDM’s Jenner Institute.

RECOVERY trial team wins the MRC Impact Prize

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Continued support to CPM helps it explore personalised medicine

The Dr Stanley Ho Medical Development Foundation will continue its funding support for The Centre for Personalised Medicine (CPM) for further seven years.

New global study links pain and genetic basis of endometriosis

Researchers at NDM’s Wellcome Centre for Human Genetics and Nuffield Department of Women’s & Reproductive Health, in collaboration with 25 teams across the world have found compelling genetic evidence linking endometriosis to other types of pain.